BLCO
Price
$16.78
Change
+$0.43 (+2.63%)
Updated
Aug 7 closing price
Capitalization
5.93B
87 days until earnings call
Intraday BUY SELL Signals
IDXX
Price
$586.67
Change
-$3.33 (-0.56%)
Updated
Aug 7 closing price
Capitalization
46.22B
86 days until earnings call
Intraday BUY SELL Signals
SNN
Price
$30.11
Change
+$0.42 (+1.41%)
Updated
Aug 7 closing price
Capitalization
12.55B
87 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BLCO or IDXX or SNN

BLCO vs IDXX vs SNN Comparison Chart in %
loading
loading
loading
View a ticker or compare two or three
A.I.Advisor
Aug 03, 2026

Which Stock Would AI Choose? Bausch + Lomb Corporation (BLCO) vs. IDEXX Laboratories, Inc. (IDXX) vs. Smith & Nephew plc (SNN) Stock Comparison

Key Takeaways

  • BLCO delivered Q2 2026 revenue of $1.39 billion, exceeding estimates by 1.7% with 9.1% year-over-year growth, and raised full-year guidance amid broad-based segment performance.
  • IDXX reported strong Q1 2026 results with 14% reported revenue growth and raised its full-year outlook; investors await Q2 results scheduled for August 4, 2026.
  • SNN beat Q1 expectations, launched a $500 million share buyback program, and received FDA De Novo classification for its TESSA Spatial Surgery System in recent weeks.
  • Sector exposure differs sharply: BLCO focuses on eye health, IDXX on veterinary diagnostics, and SNN on orthopedics and sports medicine.
  • Recent market activity shows BLCO with positive post-earnings momentum, while IDXX and SNN trade ahead of upcoming quarterly reports.
  • Valuation sensitivity and growth drivers vary, with IDXX emphasizing recurring diagnostics revenue and SNN highlighting share repurchases and product innovation.

Introduction

This comparison examines three healthcare stocks—BLCO, IDXX, and SNN—that operate in distinct niches of the medical sector. Bausch + Lomb Corporation provides eye health products, IDEXX Laboratories, Inc. specializes in veterinary diagnostics and software, and Smith & Nephew plc focuses on orthopedic and wound care devices. The analysis highlights recent performance trends, business models, and market positioning relevant to investors and traders evaluating relative strength in the current environment. It offers factual context for those assessing sector exposure, earnings momentum, and operational developments across these names.

BLCO Overview and Recent Performance

Bausch + Lomb Corporation develops and markets vision care products, ophthalmic pharmaceuticals, and surgical devices. In recent market activity, the company reported second-quarter 2026 revenue of $1.39 billion, representing 9.1% year-over-year growth and a modest beat of analyst estimates. Management raised full-year 2026 revenue guidance following broad-based gains across segments and improved adjusted EBITDA performance. Stock price behavior reflected a positive reaction to the results, with shares advancing in the immediate aftermath. Sentiment has been supported by consistent execution in core eye health categories amid stable demand for contact lenses, lens care, and surgical solutions.

IDXX Overview and Recent Performance

IDEXX Laboratories, Inc. provides diagnostic and software solutions primarily for companion animal veterinary practices, along with livestock, poultry, and water testing products. The company posted first-quarter 2026 revenue growth of 14% as reported and 11% organic, driven by companion animal group diagnostics recurring revenue. It raised its full-year 2026 revenue and earnings per share outlook. In recent weeks, attention has centered on the upcoming second-quarter results, set for release on August 4, 2026, followed by an Investor Day on August 13. Price performance has been influenced by anticipation of continued organic growth in high-margin recurring revenue streams.

SNN Overview and Recent Performance

Smith & Nephew plc manufactures orthopedic reconstruction, sports medicine, and wound management products. The company exceeded first-quarter 2026 sales expectations and announced a $500 million share repurchase program, signaling confidence in cash flow generation. Recent developments include FDA De Novo classification for the TESSA Spatial Surgery System, aimed at advancing personalized planning in sports medicine. Shares have traded in a range ahead of second-quarter and first-half results scheduled for August 4. Market sentiment reflects positioning around new technology adoption and capital return initiatives.

Trending AI Robots

Tickeron maintains a curated Trending AI Robots section that features select AI trading bots optimized for prevailing market conditions. While hundreds of AI trading bots are available across thousands of tickers, only those demonstrating strong alignment with current trends, risk parameters, and performance metrics earn placement in this highlighted area. Bots in the section exhibit varied trading styles, strategies, timeframes, and statistical profiles, including different win rates, drawdowns, and ticker coverage. Users can review detailed performance data and configurations to identify options suited to specific objectives. Explore the full selection on the Trending AI Robots page for additional insights.

Head-to-Head Comparison

Business models diverge significantly: BLCO generates revenue from consumer and professional eye health products with exposure to elective procedures; IDXX benefits from recurring diagnostics revenue in veterinary settings; and SNN relies on implant and device sales in orthopedics with emerging digital surgery tools. Growth drivers include BLCO’s segment expansion and guidance lifts, IDXX’s organic diagnostics momentum, and SNN’s product launches plus buybacks. Recent momentum favors BLCO following its earnings beat, while IDXX and SNN face near-term catalysts tied to upcoming reports. Risk factors encompass regulatory and reimbursement pressures for all three, with valuation sensitivity higher for growth-oriented names like IDXX and operational leverage differing by sector exposure. Market sentiment remains constructive on innovation and capital allocation across the group.

Tickeron AI Verdict

Based on observable factors such as recent earnings consistency, guidance updates, and relative positioning ahead of catalysts, Tickeron’s AI models currently assign a higher probabilistic weighting to BLCO due to its demonstrated revenue beat and raised outlook in the most recent reporting period. IDXX and SNN show solid underlying trends but await confirmation from pending quarterly results. This assessment reflects trend stability and near-term visibility rather than absolute rankings.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Interact to see
Advertisement
COMPARISON
Comparison
Aug 09, 2026
Stock price -- (BLCO: $16.78IDXX: $586.67SNN: $30.11)
Brand notoriety: BLCO, IDXX and SNN are all not notable
BLCO represents the Pharmaceuticals: Other industry, IDXX is part of the Medical Specialties industry, and SNN is in the Medical/Nursing Services industry.
Current volume relative to the 65-day Moving Average: BLCO: 61%, IDXX: 62%, SNN: 93%
Market capitalization -- BLCO: $5.93B, IDXX: $46.22B, SNN: $12.55B
BLCO [@Pharmaceuticals: Other] is valued at $5.93B. IDXX’s [@Medical Specialties] market capitalization is $46.22B. SNN [@Medical/Nursing Services] has a market capitalization of $12.55B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $133.83B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $186.55B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $8.39B. The average market capitalization across the [@Medical Specialties] industry is $17.8B. The average market capitalization across the [@Medical Specialties] industry is $5.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLCO’s FA Score shows that 1 FA rating(s) are green whileIDXX’s FA Score has 1 green FA rating(s), and SNN’s FA Score reflects 1 green FA rating(s).

  • BLCO’s FA Score: 1 green, 4 red.
  • IDXX’s FA Score: 1 green, 4 red.
  • SNN’s FA Score: 1 green, 4 red.
According to our system of comparison, BLCO, IDXX and SNN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLCO’s TA Score shows that 4 TA indicator(s) are bullish while IDXX’s TA Score has 7 bullish TA indicator(s), and SNN’s TA Score reflects 4 bullish TA indicator(s).

  • BLCO’s TA Score: 4 bullish, 5 bearish.
  • IDXX’s TA Score: 7 bullish, 2 bearish.
  • SNN’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, IDXX is a better buy in the short-term than SNN, which in turn is a better option than BLCO.

Price Growth

BLCO (@Pharmaceuticals: Other) experienced а -0.77% price change this week, while IDXX (@Medical Specialties) price change was +4.94% , and SNN (@Medical/Nursing Services) price fluctuated -4.59% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +4.28%. For the same industry, the average monthly price growth was +5.47%, and the average quarterly price growth was +2.65%.

The average weekly price growth across all stocks in the @Medical Specialties industry was +6.88%. For the same industry, the average monthly price growth was +8.02%, and the average quarterly price growth was +20.04%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +5.89%. For the same industry, the average monthly price growth was -1.59%, and the average quarterly price growth was -8.72%.

Reported Earning Dates

BLCO is expected to report earnings on Nov 04, 2026.

IDXX is expected to report earnings on Nov 03, 2026.

SNN is expected to report earnings on Nov 04, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (+4.28% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical Specialties (+6.88% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Medical/Nursing Services (+5.89% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDXX($46.2B) has a higher market cap than SNN($12.5B) and BLCO($5.93B). BLCO YTD gains are higher at: -1.756 vs. SNN (-6.838) and IDXX (-13.282). IDXX and SNN has higher annual earnings (EBITDA): 1.56B and 1.53B vs. BLCO (735M). SNN has more cash in the bank: 419M vs. BLCO (367M) and IDXX (201M). IDXX has less debt than SNN and BLCO: IDXX (1.11B) vs SNN (3.45B) and BLCO (5.12B). SNN has higher revenues than BLCO and IDXX: SNN (6.16B) vs BLCO (5.32B) and IDXX (4.45B).
BLCOIDXXSNN
Capitalization5.93B46.2B12.5B
EBITDA735M1.56B1.53B
Gain YTD-1.756-13.282-6.838
P/E RatioN/A41.2320.48
Revenue5.32B4.45B6.16B
Total Cash367M201M419M
Total Debt5.12B1.11B3.45B
FUNDAMENTALS RATINGS
IDXX vs SNN: Fundamental Ratings
IDXX
SNN
OUTLOOK RATING
1..100
5024
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
3
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
1677
PRICE GROWTH RATING
1..100
5460
P/E GROWTH RATING
1..100
7988
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SNN's Valuation (3) in the Medical Specialties industry is significantly better than the same rating for IDXX (80). This means that SNN’s stock grew significantly faster than IDXX’s over the last 12 months.

SNN's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as IDXX (100). This means that SNN’s stock grew similarly to IDXX’s over the last 12 months.

IDXX's SMR Rating (16) in the Medical Specialties industry is somewhat better than the same rating for SNN (77). This means that IDXX’s stock grew somewhat faster than SNN’s over the last 12 months.

IDXX's Price Growth Rating (54) in the Medical Specialties industry is in the same range as SNN (60). This means that IDXX’s stock grew similarly to SNN’s over the last 12 months.

IDXX's P/E Growth Rating (79) in the Medical Specialties industry is in the same range as SNN (88). This means that IDXX’s stock grew similarly to SNN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BLCOIDXXSNN
RSI
ODDS (%)
Bearish Trend 3 days ago
73%
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
67%
Bullish Trend 3 days ago
59%
Bullish Trend 3 days ago
66%
Momentum
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
55%
Bearish Trend 3 days ago
58%
MACD
ODDS (%)
Bullish Trend 3 days ago
62%
Bullish Trend 3 days ago
65%
Bearish Trend 3 days ago
60%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
70%
Bullish Trend 3 days ago
59%
Bearish Trend 3 days ago
56%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
53%
Bullish Trend 3 days ago
57%
Advances
ODDS (%)
Bullish Trend 13 days ago
65%
Bullish Trend 6 days ago
59%
Bullish Trend 12 days ago
57%
Declines
ODDS (%)
Bearish Trend 6 days ago
68%
Bearish Trend 18 days ago
70%
Bearish Trend 5 days ago
57%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 3 days ago
77%
Bearish Trend 3 days ago
44%
Aroon
ODDS (%)
Bearish Trend 3 days ago
77%
Bullish Trend 3 days ago
54%
Bullish Trend 3 days ago
53%
View a ticker or compare two or three
Interact to see
Advertisement
BLCO
Daily Signal:
Gain/Loss:
IDXX
Daily Signal:
Gain/Loss:
SNN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALTI4.450.11
+2.53%
AlTi Global
TRMB59.510.96
+1.64%
Trimble
TDC27.390.44
+1.63%
TERADATA Corp
FLZH1.37N/A
N/A
Flash Sports & Media Holdings Inc
SHFS0.17N/A
-1.13%
SHF Holdings Inc

BLCO and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLCO has been loosely correlated with ICUI. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if BLCO jumps, then ICUI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLCO
1D Price
Change %
BLCO100%
+2.63%
ICUI - BLCO
46%
Loosely correlated
+10.93%
CRL - BLCO
45%
Loosely correlated
+0.75%
COO - BLCO
44%
Loosely correlated
+1.24%
MTD - BLCO
44%
Loosely correlated
+0.58%
RVTY - BLCO
44%
Loosely correlated
+0.37%
More

IDXX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDXX has been loosely correlated with ALGN. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if IDXX jumps, then ALGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDXX
1D Price
Change %
IDXX100%
-0.56%
ALGN - IDXX
50%
Loosely correlated
+2.71%
SYK - IDXX
48%
Loosely correlated
+0.47%
BLCO - IDXX
45%
Loosely correlated
+2.63%
SNN - IDXX
44%
Loosely correlated
+1.41%
RVTY - IDXX
41%
Loosely correlated
+0.37%
More